Tag: hemp
-
![Xphyto (XPHY.C) advances its Oral Dissolvable Film (ODF) technology for CBD and THC medical markets]()
Xphyto (XPHY.C) advances its Oral Dissolvable Film (ODF) technology for CBD and THC medical markets
Increased product efficacy and patient convenience is anticipated through faster onset of drug action, more predictable therapeutic activity and ease of use.
-
![Xphyto (XPHY.C) updates shareholders on rapid COVID-19 (SARS-CoV-2) screening test]()
Xphyto (XPHY.C) updates shareholders on rapid COVID-19 (SARS-CoV-2) screening test
Xphyto and 3a are developing rapid screening tests for COVID-19 and other high-risk pandemic threats, including H1N1 (swine flu) and H5N1 (avian flu), with a specific focus on early pre-symptomatic and asymptomatic stages of infection
-
![Xphyto’s (XPHY.C) COVID-screener: this bio-tech company ain’t spit-balling]()
Xphyto’s (XPHY.C) COVID-screener: this bio-tech company ain’t spit-balling
Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy.
-
![World Class Extractions (PUMP.C) partners with Canopy’s (WEED.T) medical division]()
World Class Extractions (PUMP.C) partners with Canopy’s (WEED.T) medical division
“Spectrum Therapeutics’ medical patients can have confidence that their legal cannabis purchases will arrive at their door in a safe and timely fashion,” stated Rosy Mondin, CEO of World-Class
-
XPhyto (XPHY.C) advances a COVID-screener that works like a pregnancy test
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto.
-
Xphyto (XPHY.C) just unlocked a pipeline of biosensor screening projects
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly.
-
![Xphyto (XPHY.C) advances delivery system for Parkinson’s drug]()
Xphyto (XPHY.C) advances delivery system for Parkinson’s drug
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies.
-
![The Inflection Point: It’s now or never for Plus Products (PLUS.C)]()
The Inflection Point: It’s now or never for Plus Products (PLUS.C)
When weed legalized in Canada, I wasn’t a consumer participant. Smoking up has never been my jam. I know some like the ritual of it all, but I see having to prep and grind and smoke as being similar to driving stick – I mean, why not also stop your car by cutting two holes…
-
![Speakeasy (EASY.C) completes $2m loan with interest rate just 5% shy of what’s considered loan sharking]()
Speakeasy (EASY.C) completes $2m loan with interest rate just 5% shy of what’s considered loan sharking
I break laws sometimes. I speed on the highway. I possess more than the 30 gram legal limit of weed products. I sneak food into the cinema, or used to when the cinema was a thing we did in polite society. I’ve been drunk and disorderly, broken noise bylaws on a Saturday night, and I…
-
The real reason for XPhyto’s (XPHY.C) freaky gravity-defying chart
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple partnerships with universities and research centers.
